[go: up one dir, main page]

AU3065192A - Ultra-pure polysaccharide materials for medical use - Google Patents

Ultra-pure polysaccharide materials for medical use

Info

Publication number
AU3065192A
AU3065192A AU30651/92A AU3065192A AU3065192A AU 3065192 A AU3065192 A AU 3065192A AU 30651/92 A AU30651/92 A AU 30651/92A AU 3065192 A AU3065192 A AU 3065192A AU 3065192 A AU3065192 A AU 3065192A
Authority
AU
Australia
Prior art keywords
ultra
medical use
polysaccharide materials
pure polysaccharide
pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30651/92A
Inventor
James J Barry
Paul A. Higham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MTG Divestitures LLC
Original Assignee
Howmedica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howmedica Inc filed Critical Howmedica Inc
Publication of AU3065192A publication Critical patent/AU3065192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58Multistep processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/24Dialysis ; Membrane extraction
    • B01D61/243Dialysis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Sustainable Development (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU30651/92A 1991-12-20 1992-11-13 Ultra-pure polysaccharide materials for medical use Abandoned AU3065192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US812185 1985-12-23
US81218591A 1991-12-20 1991-12-20

Publications (1)

Publication Number Publication Date
AU3065192A true AU3065192A (en) 1993-07-28

Family

ID=25208795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30651/92A Abandoned AU3065192A (en) 1991-12-20 1992-11-13 Ultra-pure polysaccharide materials for medical use

Country Status (3)

Country Link
AU (1) AU3065192A (en)
PT (1) PT101140A (en)
WO (1) WO1993013136A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622834A (en) * 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
CN1062870C (en) * 1997-12-16 2001-03-07 张文沂 Method for purifying sun-flower seed low-ester pectine
WO2000029449A1 (en) * 1998-11-13 2000-05-25 Cp Kelco U.S. Inc. Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same
CN1086391C (en) * 1998-12-12 2002-06-19 中国科学院新疆化学研究所 Oligosaccharide purification method
MX2009008760A (en) 2007-02-21 2009-08-27 Mochida Pharm Co Ltd Composition for treatment of cartilage disease.
AU2008315175B2 (en) 2007-10-24 2013-12-12 Mochida Pharmaceutical Co., Ltd. Composition for treatment of joint disease
CA2705850C (en) * 2007-11-13 2016-07-19 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
ITRM20080037A1 (en) * 2008-01-23 2009-07-24 Uni Degli Studi Perugia PROCEDURE FOR THE ULTRAPURIFICATION OF ALGINATI.
ES2621452T3 (en) 2008-06-19 2017-07-04 Bender Analytical Holding B.V. Method to remove impurities from biopolymeric material
US20140213524A1 (en) 2011-08-23 2014-07-31 National University Corporation Hokkaido University Composition for regeneration of cartilage
JPWO2016114355A1 (en) * 2015-01-15 2017-04-27 国立大学法人 東京大学 Anti-adhesion composition
EP3431140B1 (en) 2016-03-14 2024-03-27 Tazuke Kofukai Nerve regeneration-inducing material
CN109069692A (en) 2016-03-23 2018-12-21 国立大学法人北海道大学 Composition for treatment of intervertebral disc
EP3485921B1 (en) * 2016-07-13 2025-07-23 Mochida Pharmaceutical Co., Ltd. Adhesion-preventing composition
JP7191007B2 (en) 2017-03-02 2022-12-16 持田製薬株式会社 Composition for treatment of fibrocartilage tissue injury
CN110545824A (en) 2017-03-07 2019-12-06 持田制药株式会社 Alginic acid liquid preparation
CN111936175A (en) * 2018-01-15 2020-11-13 持田制药株式会社 Anti-blocking composition
US11472891B2 (en) 2018-02-28 2022-10-18 Mochida Pharmaceutical Co., Ltd. Photocrosslinkable alginic acid derivative
US11472892B2 (en) 2018-03-28 2022-10-18 Mochida Pharmaceutical Co., Ltd. Reactive alginic acid derivatives
CN112236457B (en) 2018-06-14 2023-08-29 持田制药株式会社 Novel cross-linked alginic acid
WO2020262642A1 (en) 2019-06-28 2020-12-30 持田製薬株式会社 Transplantation device using chemically crosslinked alginic acid
US12479933B2 (en) 2019-09-25 2025-11-25 Mochida Pharmaceutical Co., Ltd. Crosslinked alginic acid structure
EP4079339A4 (en) 2019-12-18 2023-12-27 Mochida Pharmaceutical Co., Ltd. Novel crosslinked alginic acid
CN114980937A (en) 2020-01-14 2022-08-30 持田制药株式会社 Combination and method for treatment of subjects using alginate
US20230293782A1 (en) 2020-07-31 2023-09-21 Mochida Pharmaceutical Co., Ltd. Composition for preventing adhesion
US20240316248A1 (en) 2020-12-22 2024-09-26 Mochida Pharmaceutical Co., Ltd. Transplantation device using chemically crosslinked alginic acid
EP4268857A4 (en) 2020-12-28 2025-09-24 Mochida Pharm Co Ltd NEW MULTI-LAYER POLYMER-COATED CROSS-LINKED ALGINATE GEL FIBER
WO2022145419A1 (en) 2020-12-28 2022-07-07 持田製薬株式会社 Multilayer structure using chemically crosslinked alginic acid
CN116710110A (en) 2020-12-28 2023-09-05 持田制药株式会社 Novel multilayer polymer-coated cross-linked alginate gel fibers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA980261A (en) * 1972-08-16 1975-12-23 Uniroyal Ltd. Process for the purification and concentration of solutions derived from marine algae
NO161573C (en) * 1983-11-25 1989-08-30 Miles Inc PROCEDURE FOR THE PREPARATION OF HYALURONIC ACID.

Also Published As

Publication number Publication date
WO1993013136A1 (en) 1993-07-08
PT101140A (en) 1994-02-28

Similar Documents

Publication Publication Date Title
AU3065192A (en) Ultra-pure polysaccharide materials for medical use
AU8557591A (en) Medical device
AU1532692A (en) Surgical device
AU2578792A (en) Diaper container
AU1246492A (en) Anti-snore device
AU6018194A (en) Easy intubator
AU2470792A (en) Wheelchair
AU2186792A (en) Patient sling
AU3099992A (en) Medical environment interface
AU1935192A (en) Spinal orthosis
AU1655192A (en) Antivizal dibenzothiazepinone derivatives
AU2121092A (en) Benzodioxanderivate
AU2377792A (en) Sauna-shower adapter
AU3031092A (en) Fungicidal 2-amidazolin-5-one and 2-amidazoline-5-thione derivatives
AU9128891A (en) Single use syringe
AU1799492A (en) Blood taking device
AU2838192A (en) Catheter
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU2954692A (en) Medical preparations
AU1080292A (en) Ige-receptor-antibodies
AU2483592A (en) Diaper
AU1033992A (en) 3-quinuclidine derivatives
AU1189392A (en) Pharmaceutical agent
AU649061B2 (en) Single use syringe
AU2686592A (en) Tetraphenylporphyn derivatives